Last update 31 May 2025

FB-6001

Overview

Basic Info

Drug Type
Synthetic peptide vaccine, Therapeutic vaccine
Synonyms
FB 6001, FB6001
Target
PCSK9
Action
modulators
Mechanism
PCSK9 modulators(Proprotein convertase subtilisin kexin type 9 modulators)
Therapeutic Areas
Endocrinology and Metabolic DiseaseCardiovascular DiseasesCongenital Disorders
Active Indication-
Inactive Indication
Cardiovascular DiseasesHeterozygous familial hypercholesterolemiaHyperlipidemia, Familial Combined+ [1]
Originator Organization
Frontier Biotechnologies Inc. (Nanjing)Frontier Biotechnologies Inc. (Nanjing)
Active Organization-
Inactive Organization
Frontier Biotechnologies Inc. (Nanjing)Frontier Biotechnologies Inc. (Nanjing)AFFiRiS AGAFFiRiS AG
License Organization-
Drug Highest PhaseDiscontinuedPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

100 Clinical Results associated with FB-6001
Login to view more data
100 Translational Medicine associated with FB-6001
Login to view more data
100 Patents (Medical) associated with FB-6001
Login to view more data
100 Deals associated with FB-6001
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
HyperlipidemiasPhase 1
Europe
AFFiRiS AGAFFiRiS AG
31 Aug 2022
Cardiovascular DiseasesPreclinical
China
Frontier Biotechnologies Inc. (Nanjing)Frontier Biotechnologies Inc. (Nanjing)
31 Aug 2022
Heterozygous familial hypercholesterolemiaPreclinical
China
Frontier Biotechnologies Inc. (Nanjing)Frontier Biotechnologies Inc. (Nanjing)
31 Aug 2022
Hyperlipidemia, Familial CombinedPreclinical
China
Frontier Biotechnologies Inc. (Nanjing)Frontier Biotechnologies Inc. (Nanjing)
31 Aug 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free